• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《2020年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2020)

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).

作者信息

Egi Moritoki, Ogura Hiroshi, Yatabe Tomoaki, Atagi Kazuaki, Inoue Shigeaki, Iba Toshiaki, Kakihana Yasuyuki, Kawasaki Tatsuya, Kushimoto Shigeki, Kuroda Yasuhiro, Kotani Joji, Shime Nobuaki, Taniguchi Takumi, Tsuruta Ryosuke, Doi Kent, Doi Matsuyuki, Nakada Taka-Aki, Nakane Masaki, Fujishima Seitaro, Hosokawa Naoto, Masuda Yoshiki, Matsushima Asako, Matsuda Naoyuki, Yamakawa Kazuma, Hara Yoshitaka, Sakuraya Masaaki, Ohshimo Shinichiro, Aoki Yoshitaka, Inada Mai, Umemura Yutaka, Kawai Yusuke, Kondo Yutaka, Saito Hiroki, Taito Shunsuke, Takeda Chikashi, Terayama Takero, Tohira Hideo, Hashimoto Hideki, Hayashida Kei, Hifumi Toru, Hirose Tomoya, Fukuda Tatsuma, Fujii Tomoko, Miura Shinya, Yasuda Hideto, Abe Toshikazu, Andoh Kohkichi, Iida Yuki, Ishihara Tadashi, Ide Kentaro, Ito Kenta, Ito Yusuke, Inata Yu, Utsunomiya Akemi, Unoki Takeshi, Endo Koji, Ouchi Akira, Ozaki Masayuki, Ono Satoshi, Katsura Morihiro, Kawaguchi Atsushi, Kawamura Yusuke, Kudo Daisuke, Kubo Kenji, Kurahashi Kiyoyasu, Sakuramoto Hideaki, Shimoyama Akira, Suzuki Takeshi, Sekine Shusuke, Sekino Motohiro, Takahashi Nozomi, Takahashi Sei, Takahashi Hiroshi, Tagami Takashi, Tajima Goro, Tatsumi Hiroomi, Tani Masanori, Tsuchiya Asuka, Tsutsumi Yusuke, Naito Takaki, Nagae Masaharu, Nagasawa Ichiro, Nakamura Kensuke, Nishimura Tetsuro, Nunomiya Shin, Norisue Yasuhiro, Hashimoto Satoru, Hasegawa Daisuke, Hatakeyama Junji, Hara Naoki, Higashibeppu Naoki, Furushima Nana, Furusono Hirotaka, Matsuishi Yujiro, Matsuyama Tasuku, Minematsu Yusuke, Miyashita Ryoichi, Miyatake Yuji, Moriyasu Megumi, Yamada Toru, Yamada Hiroyuki, Yamamoto Ryo, Yoshida Takeshi, Yoshida Yuhei, Yoshimura Jumpei, Yotsumoto Ryuichi, Yonekura Hiroshi, Wada Takeshi, Watanabe Eizo, Aoki Makoto, Asai Hideki, Abe Takakuni, Igarashi Yutaka, Iguchi Naoya, Ishikawa Masami, Ishimaru Go, Isokawa Shutaro, Itakura Ryuta, Imahase Hisashi, Imura Haruki, Irinoda Takashi, Uehara Kenji, Ushio Noritaka, Umegaki Takeshi, Egawa Yuko, Enomoto Yuki, Ota Kohei, Ohchi Yoshifumi, Ohno Takanori, Ohbe Hiroyuki, Oka Kazuyuki, Okada Nobunaga, Okada Yohei, Okano Hiromu, Okamoto Jun, Okuda Hiroshi, Ogura Takayuki, Onodera Yu, Oyama Yuhta, Kainuma Motoshi, Kako Eisuke, Kashiura Masahiro, Kato Hiromi, Kanaya Akihiro, Kaneko Tadashi, Kanehata Keita, Kano Ken-Ichi, Kawano Hiroyuki, Kikutani Kazuya, Kikuchi Hitoshi, Kido Takahiro, Kimura Sho, Koami Hiroyuki, Kobashi Daisuke, Saiki Iwao, Sakai Masahito, Sakamoto Ayaka, Sato Tetsuya, Shiga Yasuhiro, Shimoto Manabu, Shimoyama Shinya, Shoko Tomohisa, Sugawara Yoh, Sugita Atsunori, Suzuki Satoshi, Suzuki Yuji, Suhara Tomohiro, Sonota Kenji, Takauji Shuhei, Takashima Kohei, Takahashi Sho, Takahashi Yoko, Takeshita Jun, Tanaka Yuuki, Tampo Akihito, Tsunoyama Taichiro, Tetsuhara Kenichi, Tokunaga Kentaro, Tomioka Yoshihiro, Tomita Kentaro, Tominaga Naoki, Toyosaki Mitsunobu, Toyoda Yukitoshi, Naito Hiromichi, Nagata Isao, Nagato Tadashi, Nakamura Yoshimi, Nakamori Yuki, Nahara Isao, Naraba Hiromu, Narita Chihiro, Nishioka Norihiro, Nishimura Tomoya, Nishiyama Kei, Nomura Tomohisa, Haga Taiki, Hagiwara Yoshihiro, Hashimoto Katsuhiko, Hatachi Takeshi, Hamasaki Toshiaki, Hayashi Takuya, Hayashi Minoru, Hayamizu Atsuki, Haraguchi Go, Hirano Yohei, Fujii Ryo, Fujita Motoki, Fujimura Naoyuki, Funakoshi Hiraku, Horiguchi Masahito, Maki Jun, Masunaga Naohisa, Matsumura Yosuke, Mayumi Takuya, Minami Keisuke, Miyazaki Yuya, Miyamoto Kazuyuki, Murata Teppei, Yanai Machi, Yano Takao, Yamada Kohei, Yamada Naoki, Yamamoto Tomonori, Yoshihiro Shodai, Tanaka Hiroshi, Nishida Osamu

机构信息

Division of Anesthesiology Department of Surgery Related Kobe University Graduate School of Medicine Kobe Japan.

Department of Traumatology and Acute Critical Medicine Osaka University Medical School Suita Japan.

出版信息

Acute Med Surg. 2021 Aug 26;8(1):e659. doi: 10.1002/ams2.659. eCollection 2021 Jan-Dec.

DOI:10.1002/ams2.659
PMID:34484801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8390911/
Abstract

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis and septic shock created as revised from J-SSCG 2016 jointly by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine, was first released in September 2020 and published in February 2021. An English-language version of these guidelines was created based on the contents of the original Japanese-language version. The purpose of this guideline is to assist medical staff in making appropriate decisions to improve the prognosis of patients undergoing treatment for sepsis and septic shock. We aimed to provide high-quality guidelines that are easy to use and understand for specialists, general clinicians, and multidisciplinary medical professionals. J-SSCG 2016 took up new subjects that were not present in SSCG 2016 (e.g., ICU-acquired weakness [ICU-AW], post-intensive care syndrome [PICS], and body temperature management). The J-SSCG 2020 covered a total of 22 areas with four additional new areas (patient- and family-centered care, sepsis treatment system, neuro-intensive treatment, and stress ulcers). A total of 118 important clinical issues (clinical questions, CQs) were extracted regardless of the presence or absence of evidence. These CQs also include those that have been given particular focus within Japan. This is a large-scale guideline covering multiple fields; thus, in addition to the 25 committee members, we had the participation and support of a total of 226 members who are professionals (physicians, nurses, physiotherapists, clinical engineers, and pharmacists) and medical workers with a history of sepsis or critical illness. The GRADE method was adopted for making recommendations, and the modified Delphi method was used to determine recommendations by voting from all committee members. As a result, 79 GRADE-based recommendations, 5 Good Practice Statements (GPS), 18 expert consensuses, 27 answers to background questions (BQs), and summaries of definitions and diagnosis of sepsis were created as responses to 118 CQs. We also incorporated visual information for each CQ according to the time course of treatment, and we will also distribute this as an app. The J-SSCG 2020 is expected to be widely used as a useful bedside guideline in the field of sepsis treatment both in Japan and overseas involving multiple disciplines.

摘要

《2020年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2020)是由日本重症医学会和日本急性医学协会联合在《2016年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2016)基础上修订而成的一套针对日本国情的脓毒症及脓毒性休克临床实践指南,于2020年9月首次发布,并于2021年2月出版。这些指南的英文版本是根据日文原版内容编写的。本指南的目的是协助医务人员做出适当决策,以改善脓毒症和脓毒性休克患者的治疗预后。我们旨在为专科医生、普通临床医生和多学科医疗专业人员提供易于使用和理解的高质量指南。J-SSCG 2016纳入了《2016年拯救脓毒症运动(SSCG 2016)》中未提及的新主题(如重症监护病房获得性肌无力[ICU-AW]、重症监护后综合征[PICS]和体温管理)。J-SSCG 2020总共涵盖22个领域,新增了4个领域(以患者和家庭为中心的护理、脓毒症治疗系统、神经重症治疗和应激性溃疡)。无论有无证据,共提取了118个重要临床问题(临床问题,CQs)。这些CQs还包括在日本特别关注的问题。这是一个涵盖多个领域的大规模指南;因此,除了25名委员会成员外,我们还得到了总共226名成员的参与和支持,这些成员包括专业人员(医生、护士、物理治疗师、临床工程师和药剂师)以及有脓毒症或危重病病史的医务人员。推荐采用GRADE方法,并采用改良德尔菲法通过全体委员会成员投票来确定推荐意见。结果,针对118个CQs,制定了79条基于GRADE的推荐意见、5条良好实践声明(GPS)、18条专家共识、27条背景问题(BQs)答案以及脓毒症的定义和诊断总结。我们还根据治疗时间进程为每个CQ纳入了视觉信息,并将以应用程序的形式发布。预计J-SSCG 2020将在日本和海外多学科的脓毒症治疗领域作为有用的床边指南被广泛使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/83245472d41b/AMS2-8-e659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/1dd78bb7f4e2/AMS2-8-e659-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/3acd4d37b961/AMS2-8-e659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/5500c4ad0280/AMS2-8-e659-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/dbbd686a0643/AMS2-8-e659-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/dd90c268a5c7/AMS2-8-e659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/3e65a4bb83ef/AMS2-8-e659-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/f136f2a8f758/AMS2-8-e659-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/2e7b19a3cd63/AMS2-8-e659-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/6dd1ded25604/AMS2-8-e659-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/1787bc77338f/AMS2-8-e659-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/8858c95963b6/AMS2-8-e659-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/ed5581437dfe/AMS2-8-e659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/5562f13535da/AMS2-8-e659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/b520efa656c9/AMS2-8-e659-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/e2fc5373ad9e/AMS2-8-e659-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/1c2d6a0f76f5/AMS2-8-e659-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/78fe4f1a29c7/AMS2-8-e659-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/fe58b7ca42a5/AMS2-8-e659-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/83bd5027ce10/AMS2-8-e659-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/11cd9364f6ae/AMS2-8-e659-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/83245472d41b/AMS2-8-e659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/1dd78bb7f4e2/AMS2-8-e659-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/3acd4d37b961/AMS2-8-e659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/5500c4ad0280/AMS2-8-e659-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/dbbd686a0643/AMS2-8-e659-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/dd90c268a5c7/AMS2-8-e659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/3e65a4bb83ef/AMS2-8-e659-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/f136f2a8f758/AMS2-8-e659-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/2e7b19a3cd63/AMS2-8-e659-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/6dd1ded25604/AMS2-8-e659-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/1787bc77338f/AMS2-8-e659-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/8858c95963b6/AMS2-8-e659-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/ed5581437dfe/AMS2-8-e659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/5562f13535da/AMS2-8-e659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/b520efa656c9/AMS2-8-e659-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/e2fc5373ad9e/AMS2-8-e659-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/1c2d6a0f76f5/AMS2-8-e659-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/78fe4f1a29c7/AMS2-8-e659-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/fe58b7ca42a5/AMS2-8-e659-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/83bd5027ce10/AMS2-8-e659-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/11cd9364f6ae/AMS2-8-e659-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3645/8390911/83245472d41b/AMS2-8-e659-g004.jpg

相似文献

1
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).《2020年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2020)
Acute Med Surg. 2021 Aug 26;8(1):e659. doi: 10.1002/ams2.659. eCollection 2021 Jan-Dec.
2
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).《2020年日本脓毒症和脓毒性休克管理临床实践指南》(J-SSCG 2020)
J Intensive Care. 2021 Aug 25;9(1):53. doi: 10.1186/s40560-021-00555-7.
3
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).《2016年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2016)
J Intensive Care. 2018 Feb 2;6:7. doi: 10.1186/s40560-017-0270-8. eCollection 2018.
4
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).《2016年日本脓毒症及脓毒性休克管理临床实践指南》(J-SSCG 2016)
Acute Med Surg. 2018 Feb 5;5(1):3-89. doi: 10.1002/ams2.322. eCollection 2018 Jan.
5
New avenues of sepsis research: obtaining perspective by analyzing and comparing SSCG 2021 and J-SSCG 2020.脓毒症研究的新途径:通过分析和比较2021年脓毒症存活指南(SSCG)和2020年日本脓毒症存活指南(J-SSCG)获取见解
J Intensive Care. 2022 Mar 7;10(1):11. doi: 10.1186/s40560-022-00606-7.
6
Japanese rapid/living recommendations on drug management for COVID-19: updated guidelines (September 2021).日本关于新型冠状病毒肺炎药物管理的快速/现行建议:更新指南(2021年9月)
Acute Med Surg. 2021 Nov 16;8(1):e706. doi: 10.1002/ams2.706. eCollection 2021 Jan-Dec.
7
Japanese rapid/living recommendations on drug management for COVID-19: updated guidelines (July 2022).日本关于COVID-19药物管理的快速/现行建议:更新指南(2022年7月)
Acute Med Surg. 2022 Oct 19;9(1):e789. doi: 10.1002/ams2.789. eCollection 2022 Jan-Dec.
8
The Japanese guidelines for the management of sepsis.日本脓毒症管理指南。
J Intensive Care. 2014 Oct 28;2(1):55. doi: 10.1186/s40560-014-0055-2. eCollection 2014.
9
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10
[Comparison between the 2020 international guidelines for the management of sepsis and septic shock and the Japanese guidelines for the management of sepsis].《2020年脓毒症和脓毒性休克国际管理指南与日本脓毒症管理指南的比较》
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 May;35(5):453-457. doi: 10.3760/cma.j.cn121430-20221227-01119.

引用本文的文献

1
Implications of Myocardial Fibrosis Burden on Left Ventricular Systolic Function in Sepsis Survivors: Insights from a Retrospective Cohort Study Using Quantitative Late Gadolinium Enhancement Cardiovascular Magnetic Resonance.脓毒症幸存者中心肌纤维化负担对左心室收缩功能的影响:一项使用定量延迟钆增强心血管磁共振的回顾性队列研究的见解
J Cardiovasc Dev Dis. 2025 Aug 13;12(8):306. doi: 10.3390/jcdd12080306.
2
Reevaluating anticoagulation therapy for sepsis-associated disseminated intravascular coagulation based on endothelial glycocalyx shedding quantification: a single-center, retrospective, observational pilot study.基于内皮糖萼脱落定量重新评估脓毒症相关弥散性血管内凝血的抗凝治疗:一项单中心、回顾性、观察性初步研究。
Front Med (Lausanne). 2025 Jul 16;12:1566753. doi: 10.3389/fmed.2025.1566753. eCollection 2025.
3

本文引用的文献

1
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).《2020年日本脓毒症和脓毒性休克管理临床实践指南》(J-SSCG 2020)
J Intensive Care. 2021 Aug 25;9(1):53. doi: 10.1186/s40560-021-00555-7.
2
Hydrocortisone with fludrocortisone for septic shock: a systematic review and meta-analysis.氢化可的松联合氟氢可的松治疗感染性休克:一项系统评价与荟萃分析
Acute Med Surg. 2020 Sep 1;7(1):e563. doi: 10.1002/ams2.563. eCollection 2020 Jan-Dec.
3
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial.老年感染性休克患者目标平均动脉压治疗的疗效(OPTPRESS):一项多中心、实用性、开放标签、随机对照试验。
Intensive Care Med. 2025 May 13. doi: 10.1007/s00134-025-07910-4.
4
Comparison of intermittent and continuous renal replacement therapy for sepsis-associated AKI: a retrospective analysis of the Japanese ICU database.脓毒症相关急性肾损伤间歇性与连续性肾脏替代治疗的比较:日本重症监护病房数据库的回顾性分析
JA Clin Rep. 2025 Apr 28;11(1):24. doi: 10.1186/s40981-025-00787-8.
5
Protein C in adult patients with sepsis: from pathophysiology to monitoring and supplementation.成年脓毒症患者的蛋白C:从病理生理学到监测与补充
J Anesth Analg Crit Care. 2025 Apr 14;5(1):21. doi: 10.1186/s44158-025-00243-0.
6
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024.《2024年日本脓毒症和脓毒性休克管理临床实践指南》
J Intensive Care. 2025 Mar 14;13(1):15. doi: 10.1186/s40560-025-00776-0.
7
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024.《2024年日本脓毒症和脓毒性休克管理临床实践指南》
Acute Med Surg. 2025 Feb 24;12(1):e70037. doi: 10.1002/ams2.70037. eCollection 2025 Jan-Dec.
8
Quality of guidelines for infection management in sepsis: a critical appraisal using the AGREE II instrument.脓毒症感染管理指南的质量:使用AGREE II工具进行的批判性评价
BMC Med Res Methodol. 2025 Feb 21;25(1):48. doi: 10.1186/s12874-025-02491-8.
9
Association between statin use and 30-day mortality among patients with sepsis-associated encephalopathy: a retrospective cohort study.他汀类药物使用与脓毒症相关性脑病患者30天死亡率之间的关联:一项回顾性队列研究。
Front Neurol. 2024 Dec 27;15:1371314. doi: 10.3389/fneur.2024.1371314. eCollection 2024.
10
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis.《2024年日本弥散性血管内凝血管理临床实践指南》。第1部分:脓毒症。
Int J Hematol. 2025 May;121(5):592-604. doi: 10.1007/s12185-024-03896-9. Epub 2024 Dec 16.
急性肾损伤中肾脏替代治疗的启动时机。
N Engl J Med. 2020 Jul 16;383(3):240-251. doi: 10.1056/NEJMoa2000741.
4
Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征的自由或保守氧疗。
N Engl J Med. 2020 Mar 12;382(11):999-1008. doi: 10.1056/NEJMoa1916431.
5
Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.拯救脓毒症运动:儿童脓毒性休克和脓毒症相关器官功能障碍管理国际指南。
Intensive Care Med. 2020 Feb;46(Suppl 1):10-67. doi: 10.1007/s00134-019-05878-6.
6
Intravenous immunoglobulin for suspected or proven infection in neonates.静脉注射免疫球蛋白用于新生儿疑似或确诊感染
Cochrane Database Syst Rev. 2020 Jan 29;1(1):CD001239. doi: 10.1002/14651858.CD001239.pub6.
7
Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study.ICU 获得性神经肌肉并发症的 5 年影响:一项前瞻性、观察性研究。
Intensive Care Med. 2020 Jun;46(6):1184-1193. doi: 10.1007/s00134-020-05927-5. Epub 2020 Jan 22.
8
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率,1990-2017 年:全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
9
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.维生素 C、氢化可的松和硫胺素与单独使用氢化可的松对感染性休克患者存活时间和脱离血管加压支持的影响:VITAMINS 随机临床试验。
JAMA. 2020 Feb 4;323(5):423-431. doi: 10.1001/jama.2019.22176.
10
Early High-Dose Vitamin D for Critically Ill, Vitamin D-Deficient Patients.危重症、维生素 D 缺乏患者的早期高剂量维生素 D 治疗。
N Engl J Med. 2019 Dec 26;381(26):2529-2540. doi: 10.1056/NEJMoa1911124. Epub 2019 Dec 11.